Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial (Q34140046)

31 July 2017

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial (English)

1 reference

multicenter clinical trial

31 July 2017

0 references

endometrial hyperplasia

1 reference

A Orbo

1

1 reference

31 July 2017

Ab Vereide

2

1 reference

31 July 2017

M Arnes

3

1 reference

31 July 2017

I Pettersen

4

1 reference

31 July 2017

B Straume

5

1 reference

31 July 2017

28 November 2013

1 reference

BJOG: an International Journal of Obstetrics and Gynaecology

31 July 2017

1 reference

31 July 2017

121

1 reference

31 July 2017

4

1 reference

31 July 2017

477-486

1 reference

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Progestin therapy of complex endometrial hyperplasia with and without atypia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

The management of endometrial hyperplasia: an evaluation of current practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment

5 July 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1471-0528.12499

Treatment for complex atypical hyperplasia of the endometrium

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155866

Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias

28 October 2018

1 reference

12 December 2020

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD

1 reference

12 December 2020

Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study

1 reference

12 December 2020

Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone

1 reference

12 December 2020

Levo-norgestrel-nova-T and precancerous lesions of the endometrium

1 reference

12 December 2020

Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia

1 reference

12 December 2020

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

12 December 2020

Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia

1 reference

12 December 2020

A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens

1 reference

12 December 2020

Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy

1 reference

12 December 2020

Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study

1 reference

12 December 2020

Computer-based morphometric image analysis of endometrial hyperplasia

1 reference

12 December 2020

Identifiers

DOI

10.1111/1471-0528.12499

1 reference

31 July 2017

1 reference

31 July 2017

1 reference